You Are Here    News


Featured news from BHIVA

Saving lives saves money: preventing mother-to-child HIV infection saves NHS £3.1 billion
by Admin, 2015-11-27 09:00

National HIV Testing Week 2015
by Admin, 2015-10-21 09:15

Sexual Health Information Exchange (SHIE)
by Admin, 2015-10-13 10:05

View more news from BHIVA

HIV-related news from NAM

Dutch research identifies relationship between HIV clinic characteristics and retention of patients in care
by Michael Carter, 2015-11-27 07:50
Dutch research published in the online edition of AIDS has provided insights into the relationship between the characteristics of HIV clinics and the retention of patients in care. All 26 specialist HIV care providers in the Netherlands had good rates of retention in care, but a number of characteristics were associated with the likelihood of

Triple DAA regimen cures hepatitis C patients with rapid response in just 3 weeks
by Liz Highleyman, 2015-11-26 08:00
Response-guided therapy using an all-oral regimen of three direct-acting antivirals cured a majority of easier-to-treat genotype 1b hepatitis C patients in just 3 weeks, according to results from the small SODAPI pilot study, presented in a late-breaking poster at the 2015 AASLD Liver Meeting last week in San Francisco. Further research will be needed to

Clinical impact of effective HCV DAAs: referrals for liver transplant drop after their introduction
by Michael Carter, 2015-11-25 10:30
The number of hepatitis C virus (HCV)-related referrals for liver transplant has declined significantly since the introduction of HCV direct-acting antivirals (DAAs), according to two US studies presented to the recent  2015 AASLD Liver Meeting in San Francisco. The approval of the second generation of DAAs was accompanied by a 23% reduction on the

France approves PrEP
by Gus Cairns, 2015-11-24 15:30
In a historic move, France has become the first country outside the USA, and the first country with a centrally-organised, reimbursable health system, to approve no-expense pre-exposure prophylaxis (PrEP) for people who need it.The French Minister of Health, Marisol Touraine, announced today that PrEP would be available from mid-December, and reimbursable through the

Study reveals potential challenges for scaling up of HCV therapy in UK
by Michael Carter, 2015-11-24 08:30
A large proportion of patients with chronic hepatitis C virus (HCV) infection in the UK have co-morbidities, hazardous use of drugs and alcohol and are taking medications that can potentially interact with HCV direct-acting antivirals, according to research presented to the 2015 AASLD Liver Meeting in San Francisco. The investigators caution that clinicians “need to be

Liver fibrosis improves after successful treatment for hepatitis C
by Liz Highleyman, 2015-11-23 11:20
A majority of people with chronic hepatitis C and advanced fibrosis or cirrhosis showed improvement in liver health following treatment, according to study findings presented last week at the 2015 AASLD Liver Meeting in San Francisco, USA. However, the researchers identified few demographic, laboratory or disease-related factors that could predict who would experience fibrosis regression